Loading...
Allosteric Conversation in the Androgen Receptor Ligand-Binding Domain Surfaces
Androgen receptor (AR) is a major therapeutic target that plays pivotal roles in prostate cancer (PCa) and androgen insensitivity syndromes. We previously proposed that compounds recruited to ligand-binding domain (LBD) surfaces could regulate AR activity in hormone-refractory PCa and discovered sev...
Saved in:
| Published in: | Mol Endocrinol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Endocrine Society
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5416996/ https://ncbi.nlm.nih.gov/pubmed/22653923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/me.2011-1281 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|